Prospective comparison of 18F-PSMA-1007 PET/CT and MRI with histopathology as the reference standard for intraprostatic tumour detection and T-staging of high-risk prostate cancer

dc.contributor.authorKivikallio, Aino
dc.contributor.authorMalaspina, Simona
dc.contributor.authorSaarinen, Irena
dc.contributor.authorSeppänen, Marko
dc.contributor.authorAnttinen, Mikael
dc.contributor.authorJambor, Ivan
dc.contributor.authorVerho, Janne
dc.contributor.authorKemppainen, Jukka
dc.contributor.authorAronen, Hannu J.
dc.contributor.authorBoström, Peter J.
dc.contributor.authorEttala, Otto
dc.contributor.authorTaimen, Pekka
dc.contributor.organizationfi=InFLAMES Lippulaiva|en=InFLAMES Flagship|
dc.contributor.organizationfi=PET-keskus|en=Turku PET Centre|
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organizationfi=iho- ja sukupuolitautioppi|en=Dermatology and Venereology|
dc.contributor.organizationfi=kirurgia|en=Surgery|
dc.contributor.organizationfi=kliininen laitos|en=Department of Clinical Medicine|
dc.contributor.organizationfi=kuvantaminen ja kliininen diagnostiikka|en=Imaging and Clinical Diagnostics|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.39855016430
dc.contributor.organization-code1.2.246.10.2458963.20.61334543354
dc.contributor.organization-code1.2.246.10.2458963.20.68445910604
dc.contributor.organization-code1.2.246.10.2458963.20.69079168212
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.contributor.organization-code1.2.246.10.2458963.20.97295082107
dc.contributor.organization-code2607100
dc.contributor.organization-code2609810
dc.converis.publication-id491454090
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/491454090
dc.date.accessioned2025-08-28T02:35:51Z
dc.date.available2025-08-28T02:35:51Z
dc.description.abstract<p>Purpose<br>To prospectively compare the ability of F-18-PSMA-1007 PET/CT and whole-body MRI (WBMRI) with DWI to detect prostate cancer (PCa) lesions and assess their local stage. Additionally, to evaluate the correlation between PSMA uptake on PET/CT and PSMA expression as assessed by immunohistochemistry. <br></p><p>Methods<br>Men with newly diagnosed unfavourable intermediate or high-risk PCa underwent F-18-PSMA-1007 PET/CT and WBMRI with DWI before robot-assisted laparoscopic prostatectomy. Diagnostic accuracy for intraprostatic tumour localization, seminal vesicle invasion (SVI), and extraprostatic extension (EPE) was evaluated using whole-mount prostatectomy specimens as the reference standard. SUVmax was compared with immunohistochemical PSMA staining intensity quantified using QuPath software. <br></p><p>Results<br>19 patients with 39 intraprostatic lesions in histopathology were included. The overall lesion detection rates for PET/CT were 84.6% and 82.1% for two independent readers, compared to 74.4% and 46.2% for MRI readers. The detection rates of index lesions were 94.7% for PET/CT and 74.0-84.0% for MRI, whereas those of non-index lesions were 70.0-75.0% for PET/CT and 20.0-65.0% for MRI. For detecting EPE, AUC values were 0.500-0.591 for PET/CT and 0.648-0.682 for MRI. For detecting SVI, AUC values ranged from 0.629 to 0.700 across both modalities. SUVmax showed a weak correlation with immunohistochemical expression of PSMA multiplied by lesion diameter (Spearman's rho = 0.427, p = 0.013). Lesion diameters measured using 30% and 40% of SUVmax, as well as prostate SUVbackground x2, showed the closest agreement with histopathological measurements. <br></p><p>Conclusion<br>F-18-PSMA-1007 PET/CT demonstrated high sensitivity in localizing intraprostatic carcinoma lesions but seemed inferior to WBMRI in detecting EPE. PSMA uptake appears to depend on both PSMA expression and lesion size. These findings highlight the complementary roles of PET/CT and MRI in the detection and tumor staging of PCa.</p>
dc.identifier.eissn1619-7089
dc.identifier.jour-issn1619-7070
dc.identifier.olddbid209373
dc.identifier.oldhandle10024/192400
dc.identifier.urihttps://www.utupub.fi/handle/11111/44611
dc.identifier.urlhttps://doi.org/10.1007/s00259-025-07208-z
dc.identifier.urnURN:NBN:fi-fe2025082788830
dc.language.isoen
dc.okm.affiliatedauthorIsotalo, Aino
dc.okm.affiliatedauthorMalaspina, Simona
dc.okm.affiliatedauthorSaarinen, Irena
dc.okm.affiliatedauthorSeppänen, Marko
dc.okm.affiliatedauthorAnttinen, Mikael
dc.okm.affiliatedauthorJambor, Ivan
dc.okm.affiliatedauthorVerho, Janne
dc.okm.affiliatedauthorKemppainen, Jukka
dc.okm.affiliatedauthorAronen, Hannu
dc.okm.affiliatedauthorBoström, Peter
dc.okm.affiliatedauthorEttala, Otto
dc.okm.affiliatedauthorTaimen, Pekka
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3122 Cancersen_GB
dc.okm.discipline3122 Syöpätauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherSPRINGER
dc.publisher.countryGermanyen_GB
dc.publisher.countrySaksafi_FI
dc.publisher.country-codeDE
dc.publisher.placeNEW YORK
dc.relation.doi10.1007/s00259-025-07208-z
dc.relation.ispartofjournalEuropean Journal of Nuclear Medicine and Molecular Imaging
dc.source.identifierhttps://www.utupub.fi/handle/10024/192400
dc.titleProspective comparison of 18F-PSMA-1007 PET/CT and MRI with histopathology as the reference standard for intraprostatic tumour detection and T-staging of high-risk prostate cancer
dc.year.issued2025

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
s00259-025-07208-z.pdf
Size:
1.44 MB
Format:
Adobe Portable Document Format